The bills still face several more months of debate before they can become a law, but this latest action still represents a meaningful step forward for cannabis law reform in Israel.
The cost of the medications has been capped at £150 ($187 dollars US) per month for the participants – a price roughly equivalent to what consumers pay in the country’s illicit market.
The platform will include free educational webinars that cover the latest evidence for medical cannabis treatments, dosing and monitoring, modes of administration, and key case study examples.
Several US states have seen an increase in traffic deaths since they gained legal access to recreational cannabis, two new studies have found.
LYPHE Group announced a new partnership with Eaststone Ltd to secure import, distribution, and other ancillary services relating to the cannabis sector in the United Kingdom.
In an open letter to the country’s home secretary, Hannah Deacon highlights how medical cannabis remains largely unavailable to patients via the National Health Service.
Members of the industry group will be able to offer up their own CBD products for safety tests, which will range from contaminant analysis to experimental rodent studies.
The registry aims to collect and analyze clinical information from patients taking medical cannabis treatments in the UK for all recognized eligible conditions.